相关临床试验
119
86 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1996
进行中（未招募）
4
3.4%
已完成
24
20.2%
尚未招募
82
68.9%
招募中
7
5.9%
暂停
2
1.7%
暂无批准数据
- The Council of Scientific and Industrial Research has launched Phenome India, a five-year nationwide health cohort study involving over 10,000 CSIR employees to develop personalized risk prediction scores for communicable and non-communicable diseases. - Phase II health camps have been completed at multiple CSIR facilities, collecting comprehensive health data including blood biochemistry, molecular assays, imaging assessments, and lifestyle patterns from participants. - The study aims to address India's rising cardio-metabolic disorders such as diabetes, obesity, and fatty liver disease by creating precision healthcare interventions tailored to the Indian population. - All collected samples will be stored at CSIR Biobank under strict anonymity protocols, with data analysis using AI and machine learning approaches to advance personalized medicine research.
- The Madras Diabetes Research Foundation (MDRF) has signed a strategic MoU with Russia's Almazov National Medical Research Centre to advance diabetes research through international collaboration. - The partnership will focus on developing new diagnostics and treatment strategies for diabetes, with particular emphasis on gestational diabetes mellitus (GDM). - Both institutions will explore artificial intelligence and precision medicine applications in diabetes care, marking a significant step toward technology-driven therapeutic approaches. - The collaboration includes joint research projects, academic exchanges, training programs, and shared publications between the Chennai-based foundation and the Saint Petersburg medical center.
